Proto Labs, Inc.

PRLB Industrials Metal Fabrication

Proto Labs, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $533.1 million, up 6.44% from fiscal 2024. In the quarter to June 2026, revenue grew 10.6%, EPS grew 100.0% and free cash flow grew 1.35%, each against the same quarter a year earlier.

85.65 1.76 −2.01%
Market cap
$2.1B
P/E
67.4×
Fwd P/E
55.0×
Dividend yield
—
F-score
7/9
Altman Z
9.63
Beneish M
−2.75
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
32.59 53.26 39.86 42.67 80.74 42.44 0.00 57.11 59.23 56.84
Piotroski F-Score
5 6 7 5 5 4 3 8 8 7
Altman Z-Score
25.81 30.64 25.73 20.71 26.49 9.90 4.85 9.42 9.47 9.63
P/S ratio
4.67 8.03 6.83 5.95 9.44 2.91 1.42 1.97 1.96 2.27
P/FCF ratio
31.72 56.35 84.95 50.69 68.41 67.43 15.58 21.70 14.28 20.01
Altman Z″-Score (non-manufacturers)
16.11 12.30 11.56 11.21 10.60 11.21 8.18 12.08 12.09 10.59
Beneish M-Score
(2.92) (2.34) (2.68) (2.95) (2.70) (1.90) (3.67) (2.81) (2.97) (2.75)
P/Operating CF
71.92 121.65 80.16 84.54 166.77 61.61 65.95 57.76 56.73 73.57
P/B ratio
3.67 6.00 5.62 4.66 6.37 1.71 0.99 1.43 1.46 1.80
Price to Tangible BV
4.00 8.82 7.75 6.21 8.18 3.64 1.77 2.51 2.62 3.17
EV/Sales
4.31 7.77 6.55 5.63 9.09 2.76 1.27 1.78 1.76 2.04
EV/EBITDA
15.96 29.19 25.14 23.31 42.70 16.66 0.00 13.67 15.85 18.45
EV/Operating CF
16.57 32.76 23.73 22.24 36.90 24.38 10.00 12.25 11.35 14.59
EV/FCF
29.26 54.53 81.41 47.96 65.82 64.04 13.95 19.58 12.86 17.97
Quick Ratio
6.09 3.37 3.73 4.58 4.38 2.89 2.24 3.58 3.24 3.13
Current Ratio
6.74 3.77 4.08 4.97 4.82 3.34 2.61 4.04 3.66 3.49
Net Debt/EBITDA
(1.35) (0.97) (1.14) (1.37) (1.73) (0.94) 1.33 (1.56) (1.84) (2.17)
Debt/Assets
0.00% 0.96% 0.00% 1.27% 0.26% 0.15% 0.28% 0.08% 0.04% 0.00%
Debt/Equity
0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.77 0.74 0.78 0.71 0.61 0.58 0.56 0.64 0.66 0.71
Operating CF/Net income
1.81 1.58 1.61 1.82 2.10 1.66 (0.60) 4.26 4.69 3.51
Capex/Depreciation
(1.80) (1.67) (3.21) (2.02) (1.44) (0.84) (0.45) (0.73) (0.26) (0.41)
ROE
12.07% 12.31% 15.28% 11.29% 8.27% 4.53% (13.56%) 2.47% 2.43% 3.16%
ROA
11.02% 11.10% 13.46% 9.85% 7.18% 3.99% (11.96%) 2.19% 2.19% 2.82%
ROIC
14.22% 12.13% 13.56% 11.51% 7.72% 3.35% (9.88%) 2.97% 2.19% 2.88%
Return on Tangible Assets
15.60% 18.00% 19.61% 14.07% 10.72% 8.16% (27.75%) 4.26% 4.50% 5.56%
Average Days of Receivables
42.26 56.51 53.17 45.71 49.08 60.85 59.99 54.38 50.58 55.75
Research and Development Expense of Revenue
7.51% 6.84% 6.45% 7.13% 8.50% 9.06% 7.83% 7.97% 8.24% 8.03%
Selling, General and Administrative Expense of Revenue
27.77% 28.46% 27.16% 26.76% 27.87% 28.30% 30.77% 30.46% 31.23% 31.54%
Intangible Assets out of Total Assets
0.08 0.28 0.24 0.22 0.19 0.47 0.38 0.39 0.40 0.38
Share Based Compensation of Revenue
0.00% 2.48% 2.45% 2.35% 3.38% 3.91% 3.59% 3.17% 3.39% 2.95%
Graham Net Nets
0.09 0.04 0.05 0.05 0.03 0.06 0.12 0.12 0.12 0.12
Graham Number
22.92 27.56 35.75 34.17 32.10 28.58 0.00 19.94 19.91 23.75
Earnings Yield
3.07% 1.88% 2.51% 2.34% 1.24% 2.36% (15.10%) 1.75% 1.69% 1.76%
Free Cash Flow Yield
3.15% 1.77% 1.18% 1.97% 1.46% 1.48% 6.42% 4.61% 7.00% 5.00%
Revenue per Share
11.30 12.93 16.51 17.07 16.25 17.67 17.82 19.24 19.96 22.29
Operating CF per Share
2.94 3.07 4.56 4.32 4.00 2.00 2.26 2.80 3.10 3.11
Capex per Share
(1.27) (1.22) (3.23) (2.32) (1.76) (1.24) (0.64) (1.05) (0.36) (0.59)
Free Cash Flow per Share
1.66 1.84 1.33 2.00 2.24 0.76 1.62 1.75 2.74 2.53
Cash per Share
4.11 3.53 4.88 5.98 6.05 2.81 2.92 3.93 4.11 5.36
Shareholders Equity per Share
14.41 17.31 20.07 21.80 24.10 30.00 25.45 26.55 26.70 28.17
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
14.41 17.31 20.07 21.80 24.10 30.00 25.45 26.55 26.70 28.17
Free Cash Flow
43.88 49.11 35.83 53.82 59.96 21.03 44.50 45.86 68.69 60.50
Working Capital
134.36 121.25 162.63 188.84 191.75 128.60 114.99 150.98 141.58 166.54
Capital Expenditures
(33.62) (32.63) (87.10) (62.23) (47.01) (34.21) (17.58) (27.42) (9.13) (14.01)
Net Current Asset Value
123.38 107.48 137.87 148.54 142.15 83.40 82.05 123.60 121.49 144.06
EV/EBIT
20.79 37.08 32.81 32.32 65.96 33.39 0.00 31.88 44.36 43.30
Capex to Sales
0.11 0.09 0.20 0.14 0.11 0.07 0.04 0.05 0.02 0.03
Price to Operating Income
22.54 38.32 34.23 34.17 68.55 35.15 0.00 35.33 49.27 48.20
Other line items
Depreciation/Fixed assets
0.13 0.12 0.12 0.12 0.12 0.14 0.15 0.15 0.16 0.16
Cash ROIC
8.99% 8.76% 5.32% 7.13% 7.42% 2.32% 5.71% 5.74% 8.88% 7.54%
Accounts Receivable Turnover
7.78 7.84 7.54 7.50 7.50 6.98 6.04 6.49 6.93 7.07
Accounts Payable Turnover
10.50 11.08 12.43 13.06 12.36 12.17 12.78 17.09 17.83 19.34
Inventory Turnover
13.74 14.64 19.38 22.16 20.69 22.10 20.41 20.70 21.39 22.17
Average Days of Payables
31.52 38.47 30.71 27.45 30.75 34.88 23.21 20.25 20.38 18.63
Days of Inventory on Hand
25.92 27.31 17.79 16.46 18.31 18.10 18.16 17.68 16.17 17.76
Average Receivables
38.33 43.92 59.12 61.18 57.93 69.89 80.82 77.67 72.24 75.42
Average Payables
12.48 13.60 16.64 17.11 17.53 21.81 21.36 16.50 15.57 15.30
Average Inventory
9.54 10.29 10.68 10.08 10.47 12.01 13.37 13.62 12.98 13.35
Average Assets
387.64 466.49 568.86 646.33 708.94 836.39 865.38 787.26 757.93 753.46
Average Common Equity
353.74 420.52 501.36 563.64 615.07 736.42 763.07 696.47 682.72 672.04

Fold the line items

Columns are period end dates